Loading...
Symbols:
Loading...
Symbols:
3SBio (SSRX)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on 3SBio (SSRX)
42 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on SSRX
- ChinaBio Today(21)
- The Sun(6)
- Centient Biotech Investor(4)
- Stockerblog (2)
- Timothy Roe(2)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(538)
- Stockerblog (158)
- SA Editor Miriam Metzinger(100)
- ChinaBio Today(56)
- George Spritzer(46)
Most commented on authors
- The Sun(34)
- ChinaBio Today(6)
- Bespoke Investment Group(5)
- Stockerblog (5)
- Interfax-China (1)
- China Bio in Review: More Fallout from Economic Crisis
- 3SBio's Q3 Hurt by Lehman Bankruptcy
- China Biotech in Review: Deals, Developments and Financials
- 3SBio Files for Approval of Anemia Treatment
- China Biotech Week in Review: Earnings, Earnings, Earnings
- 3SBio Reports Higher Q2 Revenues but Earnings Slip
- Six Key Chinese Healthcare ADRs
- China ADRs: Mixed July
- China Stocks: Top Ten by PEG
- China Biomedical Industry Evolving
- China ADRs: Severe Loss in June
- Is 3SBio Too Conservative to Move Forward?
- China ADRs: Mixed May
- China Biotech Week in Review: Earnings, Deals and Drug Development
- AMAG Pharma, 3SBio Partner to Develop Ferumoxytol Market in China
- 3SBio to Commercialize Iron Deficiency Agent in China
- China Biopharma Growth Metrics
- 3SBio’s Q1: Revenues Rise, Net Income Lags
- China Stocks: April Was Kind
- China Stocks: Still No Sign of a Bottom
- China Biotech in Review: Approvals, Deals and Company News
- 3SBio Finally Pleases Investors
- Is 3SBio the Chinese Amgen?
- New China Biopharma Investments
- 3SBio Drops on Missed Estimates
- 3SBio Plunges on Q4 Earnings Miss
- China Biotech Week in Review: East-West Interdependence in 2007
- China Biotech in Review: Effective Collaboration Between US-Asian Companies and US Investors
- 3SBio Bucks The Trend: Reports Impressive Earnings, Stock Jumps
- 3SBio Rises After Hours on Earnings
- It's More than Just Baidu: 51 Other Ways to Invest in China
- Recent Chinese IPOs Continue To Shine
- Best, Worst Performing Chinese ADRs YTD
- 3SBio Soars 23% on Analyst Opinion of Anemia Drug
- 3SBio Hits Q2 Targets, Reports 50% Increase in Revenue
- Recent Chinese IPOs On Wall Street - EDU Leads The Pack
- Biotech Stocks: InterMune Retrenches
-
Biotech Day In Review: InterMune Scaling Back Operations, MGI's Positive Trial
on Mar 21, 2007
- Biotech Week In Review: Flat Never Looked So Good
- Biotech Stocks Day-in-Review: IPOs Heat Up
- Biotech Week In Review: Biotech Treks Higher
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »